Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Genitourinary 3Gynecologic 2CNS 2Thoracic 1Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Glioblastoma 2Gliosarcoma 1Glioma 1Genetic Diseases, Inborn 1Astrocytoma 1

Interventions

Temozolomide 623Radiotherapy 411Bevacizumab 257Magnetic Resonance Spectroscopy 227Cyclophosphamide 179Radiosurgery 163Carboplatin 160Etoposide 132Radiation 129Vincristine 115Irinotecan 115Cisplatin 103Filgrastim 100Specimen Handling 90Nivolumab 88pembrolizumab 84Surgical Procedures, Operative 83Lomustine 83Topotecan 73Doxorubicin 61Melphalan 59Carmustine 57Radiotherapy, Intensity-Modulated 56sargramostim 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 51Chemotherapy, Adjuvant 51Blood Specimen Collection 51Erlotinib Hydrochloride 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Circulating Tumor DNA × CNS × Clear all
NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
5 enrolled 15 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

NCT03115138 2020-07-15

Bi-GLAM

Centre Hospitalier Universitaire, Amiens

Phase NA Terminated
19 enrolled
CNS

Glioblastoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡